It’s a moment many parents have anxiously awaited for months: Children younger than five years are now eligible for vaccination against the coronavirus, among the last Americans to qualify. Wit...

US pharmaceutical company Pfizer has set up its global drug development centre at the Indian Institute of Technology-Madras Research Park here, at an outlay of over Rs 150 crore. The centre, which em...

Giving a different vaccine as the third dose than was received for the first two shots leads to better performance compared to using the booster of same preventive, according to a study published in T...

As people across the world grapple with the prospect of living with the coronavirus for the foreseeable future, one question looms large: how soon before they need yet another shot? Not for many mont...

Research by Indian scientists has suggested that people infected with omicron after full immunisation with the AstraZeneca or Pfizer-BioNTech Covid-19 vaccines have significant immune responses that p...

Booster shots of the Pfizer-BioNTech and Moderna vaccines aren’t just preventing infections with the contagious Omicron variant —  they’re also keeping infected Americans from e...

The levels of Omicron-neutralising antibodies of people vaccinated with two doses of Russia's Sputnik V vaccine did not decline as much as of those who had Pfizer shots, according to a small study...

Consumer goods giant Unilever on Monday indicated that it would continue to chase the consumer healthcare business of GlaxoSmithKline (GSK) plc, despite the latter rejecting its “unsolicited&rdq...

The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults amid a winter surge of cases driven by the highly infectious Omicron variant. The decision...

A growing body of preliminary research suggests the Covid vaccines used in most of the world offer almost no defence against becoming infected by the highly contagious omicron variant. All vaccines s...